![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
What is LIBTAYO® (cemiplimab-rwlc) | Advanced CSCC
LIBTAYO is a prescription medication used to treat people with a type of skin cancer called cutaneous squamous cell carcinoma (CSCC) that has spread or cannot be cured by surgery or radiation. It is not known if LIBTAYO is safe and effective in children.
LIBTAYO® (cemiplimab-rwlc) in Advanced NSCLC, BCC & CSCC
LIBTAYO is a prescription medication used to treat people with a type of skin cancer called cutaneous squamous cell carcinoma (CSCC) that has spread or cannot be cured by surgery or radiation. It is not known if LIBTAYO is safe and effective in children.
Treatment for Advanced CSCC | LIBTAYO® (cemiplimab-rwlc)
LIBTAYO is a prescription medication used to treat people with a type of skin cancer called cutaneous squamous cell carcinoma (CSCC) that has spread or cannot be cured by surgery or radiation. It is not known if LIBTAYO is safe and effective in children.
Taking LIBTAYO® (cemiplimab-rwlc) | Advanced CSCC
LIBTAYO is a prescription medication used to treat people with a type of skin cancer called cutaneous squamous cell carcinoma (CSCC) that has spread or cannot be cured by surgery or radiation. It is not known if LIBTAYO is safe and effective in children.
Treating Advanced BCC | LIBTAYO® (cemiplimab-rwlc)
LIBTAYO is a prescription medicine used to treat people with a type of skin cancer called basal cell carcinoma (BCC) when your BCC cannot be removed by surgery (locally advanced BCC) or when it has spread (metastatic BCC) and have previously received treatment with a hedgehog pathway inhibitor (HHI), or cannot receive treatment with a HHI.
What is Advanced BCC? | LIBTAYO® (cemiplimab-rwlc)
LIBTAYO is a prescription medicine used to treat people with a type of skin cancer called basal cell carcinoma (BCC) when your BCC cannot be removed by surgery (locally advanced BCC) or when it has spread (metastatic BCC) and have previously received treatment with a hedgehog pathway inhibitor (HHI), or cannot receive treatment with a HHI.
Patient Stories in Advanced BCC | LIBTAYO® (cemiplimab-rwlc)
LIBTAYO is a prescription medicine used to treat people with a type of skin cancer called basal cell carcinoma (BCC) when your BCC cannot be removed by surgery (locally advanced BCC) or when it has spread (metastatic BCC) and have previously received treatment with a hedgehog pathway inhibitor (HHI), or cannot receive treatment with a HHI.
Patient Resources for LIBTAYO® (cemiplimab-rwlc) | Advanced CSCC
LIBTAYO is a prescription medication used to treat people with a type of skin cancer called cutaneous squamous cell carcinoma (CSCC) that has spread or cannot be cured by surgery or radiation. It is not known if LIBTAYO is safe and effective in children.
Treating Advanced CSCC | LIBTAYO® (cemiplimab-rwlc)
LIBTAYO is a prescription medication used to treat people with a type of skin cancer called cutaneous squamous cell carcinoma (CSCC) that has spread or cannot be cured by surgery or radiation. It is not known if LIBTAYO is safe and effective in children.
What is LIBTAYO® (cemiplimab-rwlc) | Advanced NSCLC
LIBTAYO is a prescription medication used to treat people with a type of skin cancer called cutaneous squamous cell carcinoma (CSCC) that has spread or cannot be cured by surgery or radiation. It is not known if LIBTAYO is safe and effective in children.